Education Against Tobacco Randomized Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02697409|
Recruitment Status : Unknown
Verified May 2016 by Titus J. Brinker, University of Giessen.
Recruitment status was: Active, not recruiting
First Posted : March 3, 2016
Last Update Posted : June 5, 2017
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Prevention Adolescents Schools||Behavioral: Education Against Tobacco intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Medical-student-delivered Smoking Prevention Program for Secondary Schools: The Education Against Tobacco Randomized Trial|
|Study Start Date :||March 2016|
|Estimated Primary Completion Date :||July 2019|
|Estimated Study Completion Date :||July 2019|
Experimental: Intervention group
The intervention group receives two school-based modules taking less than two hours each delivered by medical students in the schools.
Behavioral: Education Against Tobacco intervention
|No Intervention: Control group|
- Smoking prevalence measured via questionnaire. [ Time Frame: 24 months post baseline ]The difference in smoking prevalence at 24 months follow-up is the primary endpoint measured via questionnaires.
- Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire. [ Time Frame: 24 months follow-up ]Difference in attitude towards smoking between the two groups at 24 months follow-up measured via questionnaires.
- Changes in smoking behavior [ Time Frame: 24 months post baseline ]The changes in smoking behavior (smoking onset, quitting) are studied as a secondary outcome measure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02697409
|Bünde, Germany, 32257|